Phase 1 Interim Trial Results of miRagen’s Anti-Fibrotic Therapy Show Potential
Idiopathic Pulmonary Fibrosis, News
Initial results from a Phase 1 study on miRagen Therapeutics‘ investigative drug MRG-201 on healthy volunteers show potential for fibrous scar tissue in certain diseases. The company announced it will present ... Read more